Home
>
Stock Market
>
>
Natco Pharma Ltd

Natco Pharma Ltd share price and stock overview

Natco Pharma Ltd (NSE: NATCOPHARM, BSE: 524816) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE987B01026 and a face value of Rs 2. As of 24 October 2026, it trades at Rs (791.85) with a market capitalisation of Rs 15540.43 crore. Figures are live and subject to change.

Natco Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

791.85 6.70 (0.85%) upARrowC

As on: 24-Oct-2026 , 04:16 PM

Market Cap(₹Cr) 15540.43

Book Value(₹Cr) 501.202063

BSE Code : 524816 NSE Symbol : NATCOPHARM EPS(TTM) : 45.47 ISIN Demat : INE987B01026 P/E(TTM) : 17.42 Face Value(₹) : 2 Div & Yield % : 0.58

Today Market

Stock Performance

Today Market

Today's High

73,766.51

Todday's Low

72,452.37

Open at

73,665.64

Previous Close

73,249.39

Volumes

Avg Price

-125.56

Historical Performance

News

16 Oct 26

Natco Pharma reported securities dematerialization details to BSE and NSE for Q3 2026

Natco Pharma Limited submitted a certificate to the BSE Ltd and National Stock Exchange of India Ltd under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming that securities received for dematerialization have been mutilated and cancelled and the details of securities were furnished to the stock exchanges, with Venture Capital and Corporate Investments Private Limited acting as the authorized signatory.

30 Sep 26

Natco Pharma closes trading window for insiders ahead of quarterly results

Natco Pharma Limited informed the BSE Limited and National Stock Exchange of India Ltd.

25 Sep 26

Natco Pharma sets October 1, 2026, as the record date for its equity rights issue

Natco Pharma Limited has fixed October 1, 2026, as the record date for a rights issue of equity shares, according to a filing with the Bombay Stock Exchange and National Stock Exchange of India on September 25, 2026.

25 Sep 26

Natco Pharma’s board approved a Rs 12.8 billion rights issue for eligible shareholders

Natco Pharma Limited announced that its board of directors approved a rights issue of 1,70,58,082 equity shares at a price of Rs 750 per share, totaling Rs 12,79,35,61,500, to eligible shareholders as of the record date of October 1, 2026, with a rights entitlement ratio of 2 shares for every 21 shares held.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
23-10-26	785.00	797.45	778.00	791.85	569535	31611	447569469.95	22600.00
22-10-26	780.00	789.00	773.60	785.15	699649	32378	548167563.55	22687.65
21-10-26	799.00	800.65	780.00	784.45	480152	29752	376765845.40	22811.35
19-10-26	785.05	809.80	779.50	800.85	768065	39938	614142073.45	22888.95
16-10-26	786.95	788.50	780.95	785.05	497871	19594	391199161.85	23146.15
15-10-26	784.00	787.60	779.00	784.95	297976	14534	233629306.35	22997.35
14-10-26	789.15	794.00	781.00	782.65	465448	30995	365960149.10	22622.70
13-10-26	800.55	802.65	787.20	789.15	277749	21394	219994181.75	22721.95
12-10-26	789.40	804.75	789.40	800.55	501242	20172	400704122.30	22363.35
09-10-26	795.40	801.70	787.45	789.40	233109	30323	184973052.90	22520.45

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

15540.43

PE Ratio

17.42

PB Ratio

1.58

Dividend Yield

0.58

ROE

16.13

ROCE

16.42

Book Value (₹)

501.202063

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	491761	0.27	491761	2
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

491761

0.27

491761

Indian

Bodies Corporate-Indian (Promoter & Group)	33070070	18.46	33070070	4
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	50217145	28.04	50217145	12
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	4686150	2.62	4686150	4
Others	0	0.00	0	0

Sub Total

87973365

49.12

87973365

Total ShareHolding for Promoter & Group

88465126

49.39

88465126

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	25	0.00	25	1
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	28651148	16.00	28651148	223
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	6813193	3.80	6813193	17
Mutual Funds / UTI	4028972	2.25	4028972	24
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	198586	0.11	198586	15
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

39691924

22.16

39691924

280

Non Institution

Bodies Corporate	2842490	1.59	2839490	1044
Clearing Members	7	0.00	7	1
Directors & their Relatives	120223	0.07	120223	7
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	3080260	1.72	3079760	10549
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	1032859	0.58	1032759	3804
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	5758530	3.22	5758530	18
Individuals holding nominal share capital up to Rs. 1 lakh	36960375	20.64	36645900	388262
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	2088	0.00	2088	6
Others	867489	0.48	867489	2

Sub Total

50952820

28.45

50634745

403833

Total Public Shareholding

90644744

50.61

90326669

404113

Total of Promoter & Public ShareHolding

179109870

100.00

178791795

404135

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

179109870

100.00

178791795

404135

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	4,078.30	4,429.50	3,998.80	2,707.10	1,944.80
OPM (%)	36.55	51.73	41.85	31.84	10.40
OP	1,490.80	2,291.40	1,673.50	861.90	202.20
Other Income	297.60	354.50	128.10	104.60	99.00
PBIDT	1,734.10	2,550.50	1,879.50	1,040.20	362.50
INTEREST	36.70	23.90	19.20	14.50	17.70
PBDT	1,697.40	2,526.60	1,860.30	1,025.70	344.80
PBT	1,490.80	2,291.40	1,673.50	861.90	202.20
EO	0.00	0.00	0.00	0.00	0.00
PBT after EO	1,490.80	2,291.40	1,673.50	861.90	202.20
TAXES	118.90	408.00	285.20	146.60	32.20
PAT	1,418.50	1,885.40	1,388.30	715.30	170.00
EPS	79.20	105.26	77.34	39.18	9.32
Raw Material	14.55	12.11	13.07	17.56	26.70
Power and Fuel	2.38	2.10	2.22	3.03	3.93
Employee Cost	16.85	13.42	13.13	17.98	22.87
Other Manufacturing Expenses	1.88	1.50	1.19	1.47	2.31
Selling and Administration Expenses	18.74	12.56	15.28	14.69	19.40
Miscellaneous Expenses	3.24	2.01	3.28	1.30	4.20
Revenue (Growth %)	-7.93	10.77	47.72	39.20	-5.23
PBIDT (Growth %)	-32.01	35.70	80.69	186.95	-48.93
PAT (Growth %)	-24.76	35.81	94.09	320.76	-61.44
PBIDT (Margin %)	42.52	57.58	47.00	38.42	18.64
PAT (Margin %)	34.78	42.56	34.72	26.42	8.74

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	35.80	35.80	35.80	36.50	36.50	36.50
Reserves Total	8516.80	7298.10	5556.50	4665.50	4155.40	4054.60
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	8552.60	7333.90	5592.30	4702.00	4191.90	4091.10
Secured Loans	706.40	273.10	167.20	74.90	289.00	128.40
Unsecured Loans	2.90	1.50	198.90	86.20	110.50	128.00
Total Debt	709.30	274.60	366.10	161.10	399.50	256.40
Other Liabilities	67.30	70.20	74.90	87.00	97.00	100.70
Total Liabilities	9329.20	7678.70	6033.30	4950.10	4688.40	4448.20
APPLICATION OF FUNDS :
Gross Block	3993.90	3783.70	3359.50	3157.10	2977.80	2678.30
Less : Accumulated Depreciation	1328.60	1216.90	1072.80	923.30	803.60	672.40
Less:Impairment of Assets	50.00	50.00	0.00	0.00	0.00	0.00
Net Block	2615.30	2516.80	2286.70	2233.80	2174.20	2005.90
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	293.40	225.30	133.90	62.80	128.70	223.40
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3264.90	855.10	741.70	657.50	550.00	337.00
Current Assets, Loans & Advances
Inventories	723.60	642.10	596.90	616.00	697.70	769.20
Sundry Debtors	759.60	1178.20	1076.60	793.10	575.60	399.80
Cash and Bank Balance	1187.30	1856.90	864.90	412.00	100.90	262.80
Loans and Advances	1076.00	720.80	708.10	533.70	673.90	694.60
Total Current Assets	3746.50	4398.00	3246.50	2354.80	2048.10	2126.40
Less : Current Liabilities and Provisions
Current Liabilities	608.10	435.50	386.30	383.60	242.60	250.20
Provisions	350.10	155.70	134.40	25.30	17.00	12.80
Total Current Liabilities & Provisions	958.20	591.20	520.70	408.90	259.60	263.00
Net Current Assets	2788.30	3806.80	2725.80	1945.90	1788.50	1863.40
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	409.10	287.00	215.80	178.90	127.60	0.00
Deferred Tax Liability	185.00	246.00	208.70	207.80	157.60	41.30
Net Deferred Tax	224.10	41.00	7.10	-28.90	-30.00	-41.30
Other Assets	143.20	233.70	138.10	79.00	77.00	59.80
Total Assets	9329.20	7678.70	6033.30	4950.10	4688.40	4448.20
Contingent Liabilities	3.00	3.00	0.40	47.50	37.90	2.70

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	35.60	-346.80	-237.30	-212.40	302.10
Investing Activities	-92.50	-436.60	-960.50	-1,443.90	-2,078.20
Net Cash Flow	0.80	1.00	-1.40	5.70	0.30
Operating Activities	57.70	784.40	1,196.40	1,662.00	1,776.40

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

820.85

(-0.96%)

Accent Microcell...

592.50

(-3.92%)

Accretion Pharma...

182.10

(-3.80%)

Achyut Healthcar...

Advanced Enzyme ...

248.35

(-4.06%)

Akums Drugs & Ph...

669.00

(-1.65%)

Albert David Ltd

763.70

(-2.63%)

Alembic Pharmace...

760.10

(-2.71%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

VCN

V C Nannapaneni

Chairman / Executive Director / M D / Promoter

Executive

Rajeev Nannapaneni

Vice Chairman & CEO

Executive

Independent Directors

ADM

A D Murthy Chavali

Independent Non Exe. Director

Ind.

Vijayabhaskar Dronadula

Independent Non Exe. Director

Ind.

B. Lakshminarayana

Independent Non Exe. Director

Ind.

Kantipudi Suma

Independent Non Exe. Director

Ind.

Nitin Jain

Independent Non Exe. Director

Ind.

Other Officials

PSRK Prasad

ED / EVP

Board

DLR

D Linga Rao

ED & President (Corporate affa

Board

Venkat Ramesh

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Natco Pharma Ltd? −

Natco Pharma Ltd trades on NSE under NATCOPHARM and on BSE under code 524816. The ISIN is INE987B01026 and the face value is Rs 2.

What is the share price of Natco Pharma Ltd today? +

As of 24 October 2026, Natco Pharma Ltd trades at Rs 791.85, a change of 6.70 (0.85%) on the day. Prices are live and subject to change.

What is the market capitalisation of Natco Pharma Ltd? +

As of 24 October 2026, Natco Pharma Ltd has a market cap of about Rs 15540.43 crore. This figure is live and moves with the share price.

Is Natco Pharma Ltd profitable? +

In March 2026, Natco Pharma Ltd reported a profit after tax of Rs 1,418.50 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Natco Pharma Ltd? +

: As of 24 October 2026, the PE (TTM) for Natco Pharma Ltd is 17.42 and the price-to-book ratio is 1.58. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Natco Pharma Ltd pay a dividend? +

As of 24 October 2026, the dividend yield for Natco Pharma Ltd is 0.58%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Natco Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 49.39% of Natco Pharma Ltd. Public shareholding is 50.61%, including mutual funds at 2.25% and foreign institutional investors at 16.00%.

What were the latest annual financials of Natco Pharma Ltd? +

In March 2026, Natco Pharma Ltd reported net sales of Rs 4,078.30 crore, revenue growth of -7.93%, and earnings per share of Rs 79.20.